SCHEMBL1429978

SCHEMBL1429978

C[C@H]1C[N+](C(=O)[O-])(C(C)(C)C)CCN1S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 4/20 0.50
PSEN2 P49810 4/20 0.50
APH1B Q8WW43 4/20 0.50
NCSTN Q92542 4/20 0.50
APH1A Q96BI3 4/20 0.50
PSENEN Q9NZ42 4/20 0.50
LMNA P02545 1/20 0.41
ACHE P22303 1/20 0.41
AKR1C3 P42330 1/20 0.41
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TSHR P16473 1/20 0.40
POLB P06746 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HSD11B1 P28845 2/20 0.38
CASP1 P29466 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3710194 1.00 PSEN1 (0.50) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2170948 0.86 HSD11B1 (0.47) AKR1C3MEN1KMT2AALDH1A1HSD11B1
SCHEMBL1429668 0.86 HSD11B1 (0.47) AKR1C3MEN1KMT2AALDH1A1HSD11B1
SCHEMBL1550822 0.84 HSD11B1 (0.46) AKR1C3MEN1KMT2AHSD11B1
SCHEMBL1551946 0.84 HSD11B1 (0.46) AKR1C3MEN1KMT2AHSD11B1
SCHEMBL1429483 0.78 HCRTR1 (0.45) LMNAAKR1C3HCRTR1HCRTR2HSD11B1
SCHEMBL1430603 0.76 HSD11B1 (0.38) HCRTR1HCRTR2HSD11B1
SCHEMBL3712617 0.72 POLB (0.47) LMNANPSR1POLBMEN1KMT2A
SCHEMBL4971362 0.70 CCR1 (0.38) LMNAMEN1KMT2AALDH1A1HSD11B1
SCHEMBL2904347 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346828-A1 PIPERAZINE DERIVATIVES USED AS CAV2.2 CALCIUM CHANNEL MODULATORS Convergence Pharmaceuticals Limited (GB) 2011-07-27 EP disclosed
EP-2300432-A1 PIPERAZINE DERIVATIVES USED AS CAV2.2 CALCIUM CHANNEL MODULATORS Convergence Pharmaceuticals Limited (GB) 2011-03-30 EP disclosed
WO-2010102663-A1 PIPERAZINE DERIVATIVES FOR USE IN THERAPY GLAXO GROUP LIMITED (GB) 2010-09-16 WO disclosed
WO-2010007073-A1 PIPERAZINE DERIVATIVES USED AS CAV2.2 CALCIUM CHANNEL MODULATORS GLAXO GROUP LIMITED (GB) 2010-01-21 WO disclosed